Myth-Busting Adult ADHD
The most persistent misconceptions about adult and late-diagnosed ADHD, taken apart properly: why each feels reasonable, where it stops being reasonable, and what the evidence shows.
Titration, monitoring and complex cases. A practical framework for prescribers, built for the decisions that don't have a single right answer in the guideline.
Run a defensible baseline work-up before a single dose is written: cardiovascular, growth and psychiatric screening, done consistently rather than ad hoc.
Titrate stimulants and non-stimulants on a rational schedule, knowing when to hold, when to push, and when slow non-stimulant onset is being mistaken for non-response.
Run monitoring that doesn't quietly degrade into a rushed renewal once a patient looks stable: the same structured review at month one and year three.
Work through side effects and true non-response in sequence (adherence, diagnosis, alternative agent) instead of jumping straight to a medication switch.
Adjust your approach for anxiety, autism, substance use and mood disorders alongside ADHD, and hand over shared care and adult transition without the patient falling through the gap.
Prescribers involved in ADHD assessment or ongoing prescribing: GPs, psychiatrists, specialist nurses, pharmacists and other prescribing clinicians working to UK guidance.
This course carries a certificate of completion. It is not currently accredited by a third-party CPD body.
The most persistent misconceptions about adult and late-diagnosed ADHD, taken apart properly: why each feels reasonable, where it stops being reasonable, and what the evidence shows.
“Overdiagnosis epidemic” headlines sit alongside record NHS waiting lists. This course works through the data so you can hold both real risks at once, case by case.